0001209191-19-027494.txt : 20190503 0001209191-19-027494.hdr.sgml : 20190503 20190503173053 ACCESSION NUMBER: 0001209191-19-027494 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190501 FILED AS OF DATE: 20190503 DATE AS OF CHANGE: 20190503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARRITY THOMAS J CENTRAL INDEX KEY: 0001275012 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32302 FILM NUMBER: 19797371 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA, INC. CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: 609-359-3020 MAIL ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20060120 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20020520 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-01 0 0001016169 ANTARES PHARMA, INC. ATRS 0001275012 GARRITY THOMAS J C/O ANTARES PHARMA, INC. 100 PRINCETON SOUTH, SUITE 300 EWING NJ 08628 1 0 0 0 Common Stock 2019-05-01 4 M 0 30000 0.53 A 190213 D Common Stock 2019-05-01 4 S 0 30000 2.6656 D 160213 D Stock Option (right to buy) 0.53 2019-05-01 4 M 0 30000 0.00 D 2019-05-13 Common Stock 30000 0 D The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. The stock options were due to expire on May 13, 2019. The options vested and became exercisable in four equal quarterly installments following the grant date of May 14, 2009. /s/Keith Muckenhirn as attorney-in-fact for Thomas J. Garrity 2019-05-03